Browse articles from EyeWorld.org related to presbyopia. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Nailing outcomes with presbyopia-correcting IOLs is important for many reasons—one of them being patient expectations, as they are paying out of pocket for an advanced-technology lens. But even when you’ve had an excellent surgery, postop complaints can trickle in, and the possible causes for the dissatisfaction are diverse.
Dysfunctional lens syndrome has evolved from a theoretical framework to a clinically validated tool that’s reshaping patient education and surgical decision making. The dysfunctional lens staging system now plays a role in identifying the right intervention at the right time, particularly in the growing field of custom lens replacement.
➤ 510(k) clearance granted to auto kerato-refracto tonometer
➤ First patient dosed with gene therapy for Best disease
➤ Long-term data shows therapy delays geographic atrophy progression
➤ Lead gene therapy candidate to treat wet AMD and DME announced
➤ FDA accepts BLA resubmission
➤ Company news
➤ ASCRS news and events
➤ FDA approves aceclidine-based drop for presbyopia ➤ Long-term data supports efficacy of continuous wet AMD treatment ➤ First patient dosed in trial for drug eluting lacrimal canaliculus plug ➤ Acquisition news ➤ ASCRS news and events
➤ Results from second Phase 3 pivotal trial for presbyopia drop
➤ Interim Phase 2 data presented on DME, wet AMD treatment
➤ Phase 2 trial to investigate oral DME treatment
➤ First patient dosed in investigational cell therapy for photoreceptor diseases
➤ Phase 1 trial begins for minimally invasive dry AMD treatment
➤ Acquisitions and other company news
➤ ASCRS news and events
➤ FDA approves first-in-class DED drop
➤ FDA accepts NDA for topical presbyopia therapy
➤ TFOS DEWS III
➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery
➤ IND application submitted for pediatric myopia treatment
➤ Study sheds light on clinical inherited retinal diseases without genetic mutations
➤ ASCRS news and events
➤ NDA submitted to the FDA for presbyopia drop
➤ FDA issues complete response letter to dry eye NDA
➤ FDA accepts BLA resubmission for bevacizumab to treat wet AMD
➤ One-month results in Phase 1/2 trial for treating Leber congenital amaurosis in a pediatric patient
➤ ASCRS news and events
➤ ASCRS EyeWorld Weekly: View the current issue
➤ Transepithelial crosslinking NDA submission accepted
➤ Fast Track designation granted to drop being investigated for night driving impairment due to visual disturbances
➤ First-in-human interventional study for gene therapy treating Leber congenital amaurosis 4
➤ Positive outcomes observed for geographic atrophy drug
➤ Regenerative Medicine Advanced Therapy designation granted to stem cell therapy for dry AMD
➤ ASCRS news and events
